keyword
https://read.qxmd.com/read/38699528/bacillus-calmette-gu%C3%A3-rin-bcg-prostato-epididymitis-in-a-patient-treated-for-a-non-invasive-urothelial-cancer-a-case-report
#1
Ayemane Salif, Ferdinand Bigirimana, Sophie Willems, Gina Reichman, Johanna Noels, Sigi Van Den Wijngaert, Sophie Lecomte, Evelyne Maillart, Philippe Clevenbergh
INTRODUCTION: The Bacillus Calmette-Guérin (BCG) used as anti-tuberculous vaccine is also a well-known therapy for superficial urothelial cancer. Local or general side effects can occur, although it is generally well tolerated. CASE: We present the case of a 65 year-old caucasian man consulting for gross hematuria and lower urinary tract symptoms. Magnetic resonance imaging (MRI) demonstrated a non-invasive urothelial carcinoma (NMIBC) and Prostate Imaging-Reporting and Data System (PIRADS) IV lesions...
2024: IDCases
https://read.qxmd.com/read/38698943/beta-lactam-antibiotics-administration-among-adult-inpatients-with-a-beta-lactam-allergy-label-incidence-predictors-and-outcomes
#2
JOURNAL ARTICLE
Naama Epstein-Rigbi, Sharon Ziv, Marina Bulanenkova, Ruth Bouganim, Ruthy Tal-Jasper, Dror Marchaim
BACKGROUND: A beta-lactam antibiotics (BLA) allergy label is common, resulting in disadvantageous outcomes due to the usage of second-line antimicrobial agents. Noncontrolled case-series analyses report low rates of hypersensitivity reactions, following intentional/non-intentional BLA challenges among labeled inpatients. The study aims were to explore predictors and outcomes associated with hypersensitivity reactions following BLA challenge among BLA-allergic labeled inpatients. METHODS: Retrospective cohort study (2019-2020) of adult (≥18 years) inpatients (Shamir Medical Center, Israel), labeled as allergic to ≥1 BLA, who received ≥1 dose/s of BLA during their stay...
2024: Antimicrob Steward Healthc Epidemiol
https://read.qxmd.com/read/38698867/exploring-the-depths-of-igg4-insights-into-autoimmunity-and-novel-treatments
#3
REVIEW
Selen Ünlü, Blanca G Sánchez Navarro, Elif Cakan, Daniel Berchtold, Rafael Meleka Hanna, Secil Vural, Atay Vural, Andreas Meisel, Miriam L Fichtner
IgG4 subclass antibodies represent the rarest subclass of IgG antibodies, comprising only 3-5% of antibodies circulating in the bloodstream. These antibodies possess unique structural features, notably their ability to undergo a process known as fragment-antigen binding (Fab)-arm exchange, wherein they exchange half-molecules with other IgG4 antibodies. Functionally, IgG4 antibodies primarily block and exert immunomodulatory effects, particularly in the context of IgE isotype-mediated hypersensitivity reactions...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38696031/penicillin-allergy-testing-and-delabeling-for-patients-who-are-prescribed-penicillin-a-systematic-review-for-a-world-health-organization-guideline
#4
REVIEW
Rui Providencia, Ghazaleh Aali, Fang Zhu, Brian F Leas, Rachel Orrell, Mahmood Ahmad, Jonathan J H Bray, Ferruccio Pelone, Petra Nass, Eloi Marijon, Miryan Cassandra, David S Celermajer, Farhad Shokraneh
Secondary prevention with penicillin aims to prevent further episodes of acute rheumatic fever and subsequent development of rheumatic heart disease (RHD). Penicillin allergy, self-reported by 10% of the population, can affect secondary prevention programs. We aimed to assess the role for (i) routine penicillin allergy testing and the (ii) safety of penicillin allergy delabeling approaches in this context. We searched MEDLINE, Embase, CENTRAL, ClinicalTrials.gov, WHO ICTRP, ISRCTN, and CPCI-S to identify the relevant reports...
May 2, 2024: Clinical Reviews in Allergy & Immunology
https://read.qxmd.com/read/38694233/pegvaliase-for-the-treatment-of-phenylketonuria-final-results-of-a-long-term-phase-3-clinical-trial-program
#5
JOURNAL ARTICLE
Cary O Harding, Nicola Longo, Hope Northrup, Stephanie Sacharow, Rani Singh, Janet A Thomas, Jerry Vockley, Roberto T Zori, Kaleigh Bulloch Whitehall, Joshua Lilienstein, Kristin Lindstrom, Drew G Levy, Shaun Jones, Barbara K Burton
Phenylketonuria (PKU) is a genetic disorder caused by deficiency of the enzyme phenylalanine hydroxylase (PAH), which results in phenylalanine (Phe) accumulation in the blood and brain, and requires lifelong treatment to keep blood Phe in a safe range. Pegvaliase is an enzyme-substitution therapy approved for individuals with PKU and uncontrolled blood Phe concentrations (>600 μmol/L) despite prior management. Aggregated results from the PRISM clinical trials demonstrated substantial and sustained reductions in blood Phe with a manageable safety profile, but also noted individual variation in time to and dose needed for a first response...
June 2024: Molecular Genetics and Metabolism Reports
https://read.qxmd.com/read/38692921/-mast-cell-neutrophil-communication-regulates-allergic-diseases
#6
REVIEW
Ryo Suzuki
Allergic diseases (e.g., food allergies) are a growing problem, with increasing numbers of individuals experiencing them worldwide. Congruently, the adverse reactions (e.g., anaphylaxis) associated with the administration of vaccines against emerging infectious diseases such as coronavirus disease 2019 (COVID-19) have become a familiar problem. Allergic diseases, which have a wide variety of symptoms, are difficult to prevent or cure; treatment is currently limited to therapeutic drugs or allergen immunotherapy...
2024: Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan
https://read.qxmd.com/read/38692824/safety-and-immunogenicity-of-a-polyvalent-dna-protein-hiv-vaccine-with-matched-env-immunogens-delivered-as-a-prime-boost-regimen-or-coadministered-in-hiv-uninfected-adults-in-the-usa-hvtn-124-a-phase-1-placebo-controlled-double-blind-randomised-controlled-trial
#7
RANDOMIZED CONTROLLED TRIAL
Ian Frank, Shuying S Li, Nicole Grunenberg, Edgar T Overton, Samuel T Robinson, Hua Zheng, Kelly E Seaton, Jack R Heptinstall, Mary A Allen, Kenneth H Mayer, Daniel A Culver, Michael C Keefer, Sri Edupuganti, Michael N Pensiero, Vijay L Mehra, Stephen C De Rosa, Daryl E Morris, Shixia Wang, Michael S Seaman, David C Montefiori, Guido Ferrari, Georgia D Tomaras, James G Kublin, Lawrence Corey, Shan Lu
BACKGROUND: An effective HIV vaccine will most likely need to have potent immunogenicity and broad cross-subtype coverage. The aim of the HIV Vaccine Trials Network (HVTN) 124 was to evaluate safety and immunogenicity of a unique polyvalent DNA-protein HIV vaccine with matching envelope (Env) immunogens. METHODS: HVTN 124 was a randomised, phase 1, placebo-controlled, double-blind study, including participants who were HIV seronegative and aged 18-50 years at low risk for infection...
May 2024: Lancet HIV
https://read.qxmd.com/read/38690488/erythema-nodosum-leprosum-reaction-masquerading-as-rheumatoid-arthritis
#8
Kirti Deo, Aravind Reddy, Rohan Manoj, Shrishti Singh
Erythema nodosum leprosum is a type 3 hypersensitivity reaction that often presents with transient eruptions of red papules, plaques, and nodules. A 52-year-old female presented with multiple joint pain that was being treated as rheumatoid arthritis (RA), but through clinical examination, she was found to have Hansen's disease with a type 2 reaction. Hence, the importance of a thorough clinical examination is a must for the timely and correct diagnosis of patients suffering from Hansen's disease.
March 2024: Curēus
https://read.qxmd.com/read/38690445/extremely-late-diagnosis-of-hereditary-angioedema-type-i-in-an-elderly-female
#9
Jonathan Estaris, Marina Ostroukhova
This case presents an instance of an extremely delayed diagnosis of hereditary angioedema (HAE) type I in an elderly female with no significant past medical history. The patient had a prolonged history of recurrent lip swelling and itchiness dating back to her teenage years, leading to multiple visits to the emergency room (ER). These recurrent episodes were characterized by random onset and accompanied by generalized pruritus and urticaria. During these ER visits, the patient would be inappropriately treated for presumed hypersensitivity reaction due to her confounding environmental allergies presenting with urticaria, complicating and significantly delaying her diagnosis...
March 2024: Curēus
https://read.qxmd.com/read/38689136/the-safety-of-ixekizumab-in-chinese-adults-with-moderate-to-severe-plaque-psoriasis-analyses-from-a-prospective-single-arm-multicenter-12-week-observational-study
#10
JOURNAL ARTICLE
Ying Li, Lin Dang, Chengzhi Lv, Bingjiang Lin, Juan Tao, Nan Yu, Ya Deng, Huiping Wang, Xiaojing Kang, Hui Qin, Rong Chen, Jinnan Li, Yunsheng Liang, Yanhua Liang, Yuling Shi
INTRODUCTION: Ixekizumab, a monoclonal antibody against interleukin-17A, is efficacious and well tolerated for the treatment of moderate-to-severe plaque psoriasis. However, there are limited data on the real-world safety of ixekizumab in Chinese patient populations. We performed an observational study of ixekizumab for the treatment of moderate-to-severe plaque psoriasis in routine clinical practice in China. Here we present a further safety analysis of this study. METHODS: In this prospective, observational, single-arm, multicenter, post-marketing safety study, adults (≥18 years) with moderate-to-severe plaque psoriasis receiving ixekizumab were enroled at dermatology departments in hospitals across China and prospectively followed for 12 weeks or until their last dose of ixekizumab...
April 30, 2024: Drug Safety: An International Journal of Medical Toxicology and Drug Experience
https://read.qxmd.com/read/38686464/mast-cell-versus-basophil-activation-test-in-allergy-current-status
#11
REVIEW
Didier G Ebo, Rajia Bahri, Chiara Tontini, Athina L Van Gasse, Christel Mertens, Margo M Hagendorens, Vito Sabato, Jessy Elst
In the past two decades, we witnessed the evolution of the basophil activation test (BAT) from mainly research applications to a potential complementary diagnostic tool to document IgE-dependent allergies. However, BAT presents some technical weaknesses. Around 10%-15% of tested patients are non-responders, BAT can be negative immediately post-reaction and the use of fresh basophils, ideally analysed within 4 h of collection, restricts the number of tests that can be performed per sample. The need for fresh basophils is especially limiting when conducting batch analyses and interlaboratory comparisons to harmonize BAT methodology...
April 30, 2024: Clinical and Experimental Allergy
https://read.qxmd.com/read/38686384/asparaginase-specific-basophil-recognition-and-activation-predict-asparaginase-hypersensitivity-in-mice
#12
JOURNAL ARTICLE
Sanjay Rathod, Keito Hoshitsuki, Yin Zhu, Manda Ramsey, Christian A Fernandez
BACKGROUND: Asparaginase (ASNase) is a crucial part of acute leukemia treatment, but immune responses to the agent can reduce its effectiveness and increase the risk of relapse. Currently, no reliable and validated biomarker predicts ASNase-induced hypersensitivity reactions during therapy. We aimed to identify predictive biomarkers and determine immune cells responsible for anaphylaxis using a murine model of ASNase hypersensitivity. METHODS: Our preclinical study uses a murine model to investigate predictive biomarkers of ASNase anaphylaxis, including anti-ASNase antibody responses, immune complex (IC) levels, ASNase-specific binding to leukocytes or basophils, and basophil activation...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38686382/sulfasalazine-induced-drug-reaction-with-eosinophilia-and-systemic-symptoms-dress-coinfected-with-covid-19-complicated-by-hemophagocytic-lymphohistiocytosis-a-case-report
#13
Mengmeng Li, Furong Li, Yang Dai, Yunou Zhang Zeng, Xiaomei Chen
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) is characterized by a widespread maculopapular rash, lymphadenopathy, fever, and multisystem involvement. Conversely, hemophagocytic lymphohistiocytosis (HLH) is an infrequent yet critical condition presenting with fever, hepatosplenomegaly, cytopenias, coagulation abnormalities, and elevated inflammatory markers. The overlapping clinical and laboratory features between DRESS and HLH poses a significant diagnostic challenge. Secondary HLH (sHLH) typically occurs in adults triggered by viral infections, malignancies, rheumatologic diseases, or immune deficiencies...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38683088/-clinical-case-of-anaphylaxis-due-to-eye-drops
#14
JOURNAL ARTICLE
Iván Tinoco-Moran, Oscar Calderón-Liosa, Margarita Olivares-Gómez, Victor Farinango-Salazar, Iván Chérrez-Ojeda
BACKGROUND: Anaphylaxis is a severe systemic allergic reaction that can be life-threatening, timely diagnosis and treatment is required in these patients, one of the most frequent triggers is pharmacological. OBJECTIVE: To report the case of a patient who presented anaphylaxis due to eye drops. CASE REPORT: A 7-year-old male with a history of rhinitis and asthma with good control. It started with itchy eyes, ophthalmic drops were administered, composition: Polyethylene glycol 400, 0...
February 1, 2024: Revista Alergia Mexico: Organo Oficial de la Sociedad Mexicana de Alergia e Inmunología, A.C
https://read.qxmd.com/read/38683081/-anaphylaxis-due-to-legumes-case-report
#15
JOURNAL ARTICLE
Leidy Johana Alzate-Pérez, Natalia Aguirre-Morales, Libia Susana Diez-Zuluaga
BACKGROUND: Legumes belonging to the family Fabaceae of the order Fabales are a widely consumed source of protein. IgE-mediated hypersensitivity reactions to legumes have been described, the most studied allergens being peanuts and soybeans. In the Mediterranean region and India, lentils, chickpeas and peas have been considered important allergens and legumes have been reported to represent the fifth most common cause of food allergy in children under 5 years of age in Spain. In Latin America, there are few reports of allergy to legumes other than peanuts, and these are especially in the paediatric population...
February 1, 2024: Revista Alergia Mexico: Organo Oficial de la Sociedad Mexicana de Alergia e Inmunología, A.C
https://read.qxmd.com/read/38683078/-novel-tropomyosin-consensus-b-and-t-epitopes-involved-in-cross-reactivity-between-10-different-species-an-in-silico-study
#16
JOURNAL ARTICLE
Luis Fang, Dalgys Martínez, Catherine Meza-Torres, Ana Moreno-Woo, Nicole Pereira-Sanandrés, Alex Domínguez Vargas, Gloria Garavito, Eduardo Egea
OBJECTIVE: This study aimed to identify by in silico methods tropomyosin consensus B and T epitopes of shrimp species, house dust mites, insects, and nematodes associated with allergic diseases in tropical countries. METHODS: In silico analysis included tropomyosin from mites (Der p 10, Der f 10, Blo t 10), insects (Aed a 10, Per a 7, Bla g 7), shrimp (Lit v 1, Pen m 1, Pen a 1), and nematode (Asc l 3) all sequences were taken from the UniProt database. Linear IgE epitopes were predicted with AlgPred 2...
February 1, 2024: Revista Alergia Mexico: Organo Oficial de la Sociedad Mexicana de Alergia e Inmunología, A.C
https://read.qxmd.com/read/38683075/-molecular-mimicry-between-human-thyroid-peroxidase-thyroglobulin-cosinophil-peroxidase-il-24-and-microorganisms-antigens
#17
JOURNAL ARTICLE
Andrés Sánchez, Valentina García, Yuliana Marcela Emiliani-Navarro, Jorge Sánchez, Juan Camilo Ramos-Gomez, Sonia Karina González-Rangel, Marlon Munera-Gomez
OBJECTIVE: Identify molecular mimicry between TPO, eosinophil peroxidase (EPX), thyroglobulin and IL24 and microorganism antigens. METHODS: Through in silico analysis, we performed local alignments between human and microorganism antigens with PSI-BLAST. Proteins that did not present a 3D structure were modeled by homology through the Swiss Modeller server and epitope prediction was performed through Ellipro. Epitopes were located in the 3D models using PYMOL software...
February 1, 2024: Revista Alergia Mexico: Organo Oficial de la Sociedad Mexicana de Alergia e Inmunología, A.C
https://read.qxmd.com/read/38683073/-case-series-of-hereditary-angioedema-patients-and-use-of-tranexamic-acid-treatments-in-prophylaxis-and-acute-crisis-experience-in-per%C3%A3%C2%BA
#18
JOURNAL ARTICLE
Oscar Calderón, Danny Muñoz, Margarita Olivares
BACKGROUND: Hereditary Angioedema (HAE) is a rare disease characterized by episodes of swelling, HAE crisis could cause death by suffocation, and also affect the quality of life in these patients. There exists an important disparity of HAE specific treatments between countries, inclusive in the same region, currently in Perú we use moderate and high doses of Tranexamic Acid (TA) in prophylaxis therapy and in acute HAE crisis respectively. OBJECTIVE: To report our experience with TA in three types of HAE patients and be a guide to other countries with this therapy, where HAE specific treatments are not registered...
February 1, 2024: Revista Alergia Mexico: Organo Oficial de la Sociedad Mexicana de Alergia e Inmunología, A.C
https://read.qxmd.com/read/38683062/-risk-factors-associated-to-adverse-drug-events-in-hospitalized-patients
#19
JOURNAL ARTICLE
María Del Rocío Hernández-Morales, Jorge Manuel Ramírez-Sánchez, Eleazar Mancilla-Hernández, Norma Lara-Dávalos, Samara Nazarala-Sanchez, Margarita Aguirre-Barbosa
OBJECTIVE: To determine prevalence, causes and risk factors of ADE in hospitalized patients. METHODS: Analytical, observational, case-control study of patients with ADE. For statistical analysis, the following were calculated: percentages, frequencies, averages; odds ratio, χ2 test and multiple binary logistic regression. Data analysis was carried out with the Statistical Package, for the Social Sciences 23 program. RESULTS: A 132 patients were registered: 66 cases (26 EM and 40 RAM) and 66 controls; with average age of 35 years (SD 17...
February 1, 2024: Revista Alergia Mexico: Organo Oficial de la Sociedad Mexicana de Alergia e Inmunología, A.C
https://read.qxmd.com/read/38682791/acute-interstitial-nephritis-in-patients-with-inflammatory-bowel-disease-treated-with-vedolizumab-a-systematic-review
#20
REVIEW
Anders Forss, Paulina Flis, Adonis Sotoodeh, Marjo Kapraali, Staffan Rosenborg
BACKGROUND: Acute interstitial nephritis (AIN) is a complication of drugs that may cause permanent kidney injury. AIN has been reported in patients with inflammatory bowel disease (IBD) treated with the integrin inhibitor vedolizumab. Through systematic review of existing literature, we aimed to identify and describe cases of AIN in patients with IBD treated with vedolizumab. METHODS: We searched Medline, Embase, Cochrane, and Web of Science Core Collection between 1 January 2009 and 25 April 2023...
April 29, 2024: Scandinavian Journal of Gastroenterology
keyword
keyword
54999
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.